Riyadh – Mubasher: Al Hammadi Company for Development and Investment has purchased equity of 35% in Sudair Pharmaceuticals.
The total value of the stake acquisition transaction is SAR 118.12 million, according to a bourse disclosure on Tuesday.
The 35% equity was owned by Gulf Investment Corporation (GIC), Al Hammadi noted.
The listed firm announced the completion of the due diligence of the financial, legal, administrative, and operational conditions.
The approvals of all relevant authorities have been secured, and the financial valuation has been completed.
